Developing an Imaging-Based Tool to Identify Areas for Prostate Cancer Biopsy

MRI Derived Quantitative Risk Maps for Prostate Cancer Diagnosis Using Targeted Biopsy

The purpose of the proposed research is to test and validate a Risk Map decision-support system (DSS) for prostate cancer Magnetic Resonance Imaging (MRI) interpretation and identification of clinically significant tumor site(s).

Inclusion Criteria:

• Patients with known or suspected prostate cancer who have been referred to the Department of Radiology at the University of Chicago Medical Center for a diagnostic MRI exam of the prostate, to be followed by an MRI-guided fusion biopsy of the prostate.
• Written informed consent.

Exclusion Criteria:

• Patients incapable of giving informed written consent;
• Patients who cannot adhere to the experimental protocols for any reason, or have an inability to communicate with the researcher;
• Patients with psychiatric disorders that affect their ability to consent for themselves will be excluded and not the entire population of patients with psychiatric disorders.
• Prisoners;
• Minor children (under the age of 18 years old).